Metraipolis › archive › dc_2272efacf45b

Non-ICANS neurotoxicities CD19-directed CAR T-cell therapy and the emergence of movement and neurocognitive treatment-emergent adverse events: a case report — Europe PMC PMID:41777880

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41777880
DOI
10.3389/fimmu.2026.1749587
License (as archived)
solo-consultazione
Archived
2026-11-05T18:59:09.351Z
SHA-256 of the archived text
0e41b3098f7c4e22bfd9f35e3694d14c1f67abb38cd8b335027db3e18f2dde08
Stable URL of this page
https://metraipolis.com/documento/dc_2272efacf45b

How to cite

Non-ICANS neurotoxicities CD19-directed CAR T-cell therapy and the emergence of movement and neurocognitive treatment-emergent adverse events: a case report — Europe PMC PMID:41777880 — Europe PMC (en), https://europepmc.org/article/MED/41777880 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2272efacf45b (Metraipolis archive dc_2272efacf45b, sha256 0e41b3098f7c4e22bfd9f35e3694d14c1f67abb38cd8b335027db3e18f2dde08)
BibTeX
@misc{dc2272efacf45b,
  title = {Non-ICANS neurotoxicities CD19-directed CAR T-cell therapy and the emergence of movement and neurocognitive treatment-emergent adverse events: a case report — Europe PMC PMID:41777880},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41777880},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2272efacf45b; sha256 0e41b3098f7c4e22bfd9f35e3694d14c1f67abb38cd8b335027db3e18f2dde08},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41777880. Agents can read the archived copy with the MCP tool read_document.